Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States)

NCT01671007 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01671007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01671007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients With Atrial Fibrillation (Phase II/III - EU/EEA Member States)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
August 22, 2012
Completion date
December 13, 2019
Enrollment
10,471 (actual)
Sites
522

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, stroke